FDA Finalizes REMS Program for ESAs,; Amgen Continues to Study Risks -- limited information in text/article Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, May 05, 2010

FDA Finalizes REMS Program for ESAs,; Amgen Continues to Study Risks -- limited information in text/article



Note: extract of article - limited information (requires subscription/$$)

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.